Prospect: information for the user
Quetiapina Alter 150 mg prolonged-release tablets EFG
Quetiapina Alter 200 mg prolonged-release tablets EFG
Quetiapina Alter 300 mg prolonged-release tablets EFG
Quetiapina Alter 400 mg prolonged-release tablets EFG
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
1. What isQuetiapina Alterand for what it is used
2. What you need to know before starting to takeQuetiapina Alter
3. How to takeQuetiapina Alter
4. Possible adverse effects
5. Storage ofQuetiapina Alter
6. Contents of the package and additional information
Quetiapina Alter contains a substance called quetiapine. It belongs to a group of medications called antipsychotics. Quetiapina Alter can be used to treat various diseases, such as:
When using Quetiapina Alter to treat major depressive episodes in major depressive disorder, it will be taken in addition to another medication that is being used to treat this disease.
Your doctor may continue prescribing Quetiapina Alter even when you are feeling better.
If you have any doubts, consult your doctor or pharmacist before taking this medication.
Warnings and precautions
Consult your doctor or pharmacist before starting to take quetiapine:
if you have depression or other conditions treated with antidepressants. The use of these medications with quetiapine may cause serotonin syndrome, a potentially life-threatening condition (see "Other medications and quetiapine").
Inform your doctor immediately if after taking quetiapine you experience any of the following:
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to be effective, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Severe skin reactions (SCARs)
Very rarely, severe skin reactions (SCARs) have been reported with the use of this medication, which may put your life at risk or be fatal. These usually manifest as:
•Stevens-Johnson syndrome (SSJ), a generalized rash with blisters and skin peeling, particularly around the mouth, nose, eyes, and genitals.
•Toxic epidermal necrolysis (TEN), a more severe form that causes extensive skin peeling.
•Drug reaction with eosinophilia and systemic symptoms (DRESS), which consists of flu-like symptoms with rash, fever, swollen lymph nodes, and abnormal blood test results (including increased white blood cell count (eosinophilia) and elevated liver enzymes).
•Acute generalized pustular psoriasis (AGEP), small pus-filled blisters.
•Multiforme erythema (EM), skin rashes with irregular red patches that itch.
If you develop these symptoms, stop using quetiapine prolonged-release and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should regularly monitor your weight.
Children and adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
Other medications and Quetiapina Alter
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take Quetiapina Alter if you are using any of the following medications:
-Some HIV medications.
-Azole-type medications (for fungal infections).
-Erythromycin or clarithromycin (for infections).
-Nefazodone (for depression).
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Taking Quetiapina Alter with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before using this medication. Do not take quetiapine during pregnancy, unless you have consulted your doctor. Do not use quetiapine if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborns of mothers who have used this medication in the last trimester (last three months of their pregnancy): tremors, muscle stiffness, or weakness, drowsiness, agitation, respiratory problems, and feeding difficulties. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
These tablets may make you feel drowsy. Do not drive or operate tools or machinery until you know how the tablets affect you.
Quetiapina Alter contains lactose
Quetiapina Alter contains lactose, a type of sugar. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medication.
Effect on drug detection tests in urine
If you are undergoing a urine drug detection test, taking Quetiapina Alter may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your condition and needs, but will usually be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quetiapina should not be used in children and adolescents under 18 years of age.
If you take more Quetiapina Alter than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you take more quetiapina than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats.
If you forget to take Quetiapina Alter
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Quetiapina Alter
If you stop taking quetiapina abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
orBoth men and women may experience breast swelling and unexpected milk production.
orWomen may not have a menstrual period or have irregular periods.
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Unknown: the frequency cannot be estimated from available data
The class of medications to which quetiapine belongs may cause heart rhythm problems that can be serious and, in severe cases, fatal.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or blood sugar, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Prolactin increases may, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Additional side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common: may affect more than 1 in 10 people
orBoth boys and girls may experience breast swelling and unexpected milk production.
orGirls may not have a menstrual period or have irregular periods.
Common: may affect up to 1 in 10 people
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es/. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Quetiapina Alter does not require special conditions for conservation.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Quetiapina Alter
-The active ingredient is quetiapine. Quetiapina Alter tablets contain 150 mg, 200 mg, 300 mg, and 400 mg of quetiapine (as quetiapine fumarate).
-The other components are:
Tablet core: Copolymer of methacrylic acid and ethyl acrylate (1:1), anhydrous lactose (lactose), crystalline maltose, talc, magnesium stearate
Tablet coating: Copolymer of methacrylic acid and ethyl acrylate (1:1), triethyl citrate
Appearance of Quetiapina Alter and content of the container
Quetiapina Alter 150 mg tablets are white, oblong, biconvex, and have “150” engraved on one face
Quetiapina Alter 200 mg tablets are white, oblong, biconvex, and have “200” engraved on one face
Quetiapina Alter 300 mg tablets are white, oblong, biconvex, and have “300” engraved on one face
Quetiapina Alter 400 mg tablets are white, oval, biconvex, and have “400” engraved on one face
They are presented in blisters of polychlorotrifluoroethylene and polyvinyl chloride with aluminum
The container sizes are:
Quetiapina Alter 150 mg: 60 tablets
Quetiapina Alter 200 mg: 60 tablets
Quetiapina Alter 300 mg: 60 tablets
Quetiapina Alter 400 mg: 60 tablets
Only some container sizes may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Alter Laboratories, S.A.
Mateo Inurria, 30
28036 Madrid
Spain
Responsible for manufacturing:
Pharmathen International S.A
Industrial Park Sapes,
Rodopi Prefecture, Block No 5,
Rodopi 69300,
Greece
or
Pharmathen S.A.
Dervenakion 6
Pallini 15351
Attiki,
Greece
Last review date of this leaflet:July 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.